People
McKenzie Cato's expertise is assisting medical device, pharmaceutical, and food and beverage companies with pre- and post-market regulatory topics. McKenzie helps companies in developing their FDA regulatory strategy, preparing regulatory submissions, responding to FDA requests for information and data, drafting regulatory policies and procedures, and reviewing advertising and promotional materials. McKenzie also assists companies with FDA, DOJ, and DEA enforcement matters, regulatory due diligence, and state regulatory and licensing issues.
Juris Doctor, George Washington University Law School, honors
B.S. Chemistry, Georgetown University
District of Columbia
Pennsylvania
April 4, 2025
FDA's LDT Rule Struck Down by Court: FDA Has Lost the Battle, But Is the War Over?
January 27, 2025
FDA Releases Proposed Front-of-Package Nutrition Labeling Rule
January 10, 2025
FDA Releases Draft Guidance on Submission Recommendations for AI-Enabled Device Software Functions
April 4, 2025
FDA's LDT Rule Struck Down by Court: FDA Has Lost the Battle, But Is the War Over?
January 27, 2025
FDA Releases Proposed Front-of-Package Nutrition Labeling Rule
January 10, 2025
FDA Releases Draft Guidance on Submission Recommendations for AI-Enabled Device Software Functions
Juris Doctor, George Washington University Law School, honors
B.S. Chemistry, Georgetown University
District of Columbia
Pennsylvania